Treace Medical Concepts, Inc. (TMCI) Tops Q3 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $50.2 million versus the consensus estimate of $49.66 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• M&T Bank Corp. (MTB) Tops Q2 EPS by 69c
• Piper Sandler Downgrades Universal Insurance Holdings (UVE) to Neutral
• Macquarie cuts India oil and gas earnings forecasts on losses